Dimri Manjari, Naramura Mayumi, Duan Lei, Chen Jing, Ortega-Cava Cesar, Chen Gengsheng, Goswami Rasna, Fernandes Norvin, Gao Qingshen, Dimri Goberdhan P, Band Vimla, Band Hamid
Division of Molecular Oncology, Evanston Northwestern Healthcare Research Institute, Evanston, IL 60201, USA.
Cancer Res. 2007 May 1;67(9):4164-72. doi: 10.1158/0008-5472.CAN-06-2580.
Epidermal growth factor receptor (EGFR), a member of the ErbB family of receptor tyrosine kinases, is overexpressed in as many as 60% cases of breast and other cancers. EGFR overexpression is a characteristic of highly aggressive molecular subtypes of breast cancer with basal-like and BRCA1 mutant phenotypes distinct from ErbB2-overexpressing breast cancers. Yet, EGFR is substantially weaker compared with ErbB2 in promoting the oncogenic transformation of nontumorigenic human mammary epithelial cells (human MEC), suggesting a role for cooperating oncogenes. Here, we have modeled the co-overexpression of EGFR and a biologically and clinically relevant potential modifier c-Src in two distinct immortal but nontumorigenic human MECs. Using a combination of morphologic analysis and confocal imaging of polarity markers in three-dimensional Matrigel culture together with functional analyses of early oncogenic traits, we show for the first time that EGFR and c-Src co-overexpression but not EGFR or c-Src overexpression alone unleashes an oncogenic signaling program that leads to hyperproliferation and loss of polarity in three-dimensional acinar cultures, marked enhancement of migratory and invasive behavior, and anchorage-independent growth. Our results establish that EGFR overexpression in an appropriate context (modeled here using c-Src overexpression) can initiate oncogenic transformation of nontumorigenic human MECs and provide a suitable in vitro model to interrogate human breast cancer-relevant oncogenic signaling pathways initiated by overexpressed EGFR and to identify modifiers of EGFR-mediated breast oncogenesis.
表皮生长因子受体(EGFR)是受体酪氨酸激酶ErbB家族的成员之一,在多达60%的乳腺癌和其他癌症病例中过度表达。EGFR的过度表达是具有基底样和BRCA1突变表型的高侵袭性乳腺癌分子亚型的特征,这些亚型与ErbB2过表达的乳腺癌不同。然而,与ErbB2相比,EGFR在促进非致瘤性人乳腺上皮细胞(人MEC)的致癌转化方面要弱得多,这表明需要协同致癌基因发挥作用。在这里,我们在两种不同的永生化但非致瘤性人MEC中模拟了EGFR和一种生物学和临床相关的潜在调节因子c-Src的共表达。通过在三维基质胶培养中结合形态学分析和极性标记物的共聚焦成像以及早期致癌特征的功能分析,我们首次表明,EGFR和c-Src的共表达而非单独的EGFR或c-Src过表达会引发致癌信号程序,导致三维腺泡培养中的细胞过度增殖和极性丧失、迁移和侵袭行为显著增强以及不依赖贴壁生长。我们的结果表明,在适当的环境中(此处使用c-Src过表达进行模拟)EGFR的过表达可以启动非致瘤性人MEC的致癌转化,并提供一个合适的体外模型来研究由过表达的EGFR引发的与人类乳腺癌相关的致癌信号通路,并鉴定EGFR介导的乳腺肿瘤发生的调节因子。